Your browser doesn't support javascript.
loading
Using 30-day modified rankin scale score to predict 90-day score in patients with intracranial hemorrhage: Derivation and validation of prediction model.
Baker, William L; Sharma, Mukul; Cohen, Alexander; Ouwens, Mario; Christoph, Mary J; Koch, Bruce; Moore, Timothy E; Frady, Garrett; Coleman, Craig I.
Affiliation
  • Baker WL; University of Connecticut School of Pharmacy, Storrs, CT, United States of America.
  • Sharma M; Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, United States of America.
  • Cohen A; Division of Neurology, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Ouwens M; Guy's and St. Thomas' Hospitals, King's College London, London, United Kingdom.
  • Christoph MJ; Medical and Payer Evidence, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.
  • Koch B; AstraZeneca Pharmaceuticals, Wilmington, DE, United States of America.
  • Moore TE; AstraZeneca Pharmaceuticals, Wilmington, DE, United States of America.
  • Frady G; Statistical Consulting Services, Center for Open Research Resources & Equipment, University of Connecticut, Storrs, CT, United States of America.
  • Coleman CI; Department of Statistics, University of Connecticut, Storrs, CT, United States of America.
PLoS One ; 19(5): e0303757, 2024.
Article in En | MEDLINE | ID: mdl-38771834
ABSTRACT
Whether 30-day modified Rankin Scale (mRS) scores can predict 90-day scores is unclear. This study derived and validated a model to predict ordinal 90-day mRS score in an intracerebral hemorrhage (ICH) population using 30-day mRS values and routinely available baseline variables. Adults enrolled in the Antihypertensive Treatment of Acute Cerebral Hemorrhage-2 (ATACH-2) trial between May 2011 and September 2015 with acute ICH, who were alive at 30 days and had mRS scores reported at both 30 and 90 days were included in this post-hoc analysis. A proportional odds regression model for predicting ordinal 90-day mRS scores was developed and internally validated using bootstrapping. Variables in the model included mRS score at 30 days, age (years), hematoma volume (cm3), hematoma location (deep [basal ganglia, thalamus], lobar, or infratentorial), presence of intraventricular hemorrhage (IVH), baseline Glasgow Coma Scale (GCS) score, and National Institutes of Health Stroke Scale (NIHSS) score at randomization. We assessed model fit, calibration, discrimination, and agreement (ordinal, dichotomized functional independence), and EuroQol-5D ([EQ-5D] utility weighted) between predicted and observed 90-day mRS. A total of 898/1000 participants were included. Following bootstrap internal validation, our model (calibration slope = 0.967) had an optimism-corrected c-index of 0.884 (95% CI = 0.873-0.896) and R2 = 0.712 for 90-day mRS score. The weighted ĸ for agreement between observed and predicted ordinal 90-day mRS score was 0.811 (95% CI = 0.787-0.834). Agreement between observed and predicted functional independence (mRS score of 0-2) at 90 days was 74.3% (95% CI = 69.9-78.7%). The mean ± SD absolute difference between predicted and observed EQ-5D-weighted mRS score was negligible (0.005 ± 0.145). This tool allows practitioners and researchers to utilize clinically available information along with the mRS score 30 days after ICH to reliably predict the mRS score at 90 days.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Intracranial Hemorrhages Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Intracranial Hemorrhages Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2024 Document type: Article Affiliation country: Country of publication: